Apremilast nio 10 mg + 20mg + 30 mg film-coated tablets

Licence holder

nio Health GmbH (all products →)

Active substances

Apremilast, Apremilast, Apremilast

Dosage form

Film-coated tablet

Route of administration

Oral use

ATC code

L04AA32

First authorised

07/11/2025

Prescription status

Product subject to prescription which may not be renewed (A)

Supply

Supply through pharmacies only

Legal basis

Generic application (Article 10(1) of Directive No 2001/83/EC)

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.